2021 annual financial data
BioRestorative Therapies 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was -7,238.93%.
Operating income was -26,307,873 USD and net income was -44,303,295 USD.
Operating cash flow was -3,329,908 USD.
Get free BioRestorative Therapies email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 46,000 USD
- Operating income
- -26,307,873 USD
- Net income
- -44,303,295 USD
- Operating cash flow
- -3,329,908 USD